ArticleOncotarget2014

The anti-tumor activator sMEK1 and paclitaxel additively decrease expression of HIF-1α and VEGF via mTORC1-S6K/4E-BP-dependent signaling pathways.

Boh-Ram Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.